Şunu aradınız:: carcinogenicity (Almanca - İngilizce)

carcinogenicity testing
carcinogenicity testing

carcinogenicity: testing of carcinogenicity of pharmaceuticals
carcinogenicity: testing of carcinogenicity of pharmaceuticals

addendum to ‘dose selection for carcinogenicity studies of
addendum to ‘ dose selection for carcinogenicity studies of cpmp/ ich/ 366/ 95 (s1c (r))

titel der leitlinie carcinogenicity: testing for carcinogenicity of pharmaceuticals
carcinogenicity: testing for carcinogenicity of pharmaceuticals

addendum on the limit dose related to: dose selection for carcinogenicity studies of pharmaceuticals
addendum on the limit dose related to: dose selection for carcinogenicity studies of pharmaceuticals

swp conclusions and recommendations with regard to the use of genetically modified animal models for carcinogenicity assessment
swp conclusions and recommendations with regard to the use of genetically modified animal models for carcinogenicity assessment

concerns have been raised about the toxicity and potential carcinogenicity of fc, and alternatives have been proposed.
concerns have been raised about the toxicity and potential carcinogenicity of fc, and alternatives have been proposed.

yasui m et al. (1997): carcinogenicity test of 50 hz sinusoidal magnetic fields in rats.
yasui m et al. (1997): carcinogenicity test of 50 hz sinusoidal magnetic fields in rats.

mandeville r et al. (1997): evaluation of the potential carcinogenicity of 60 hz linear sinusoidal...
mandeville r et al. (1997): evaluation of the potential carcinogenicity of 60 hz linear sinusoidal...

carcinogenicity testing pre-authorisation studies to assess the potential for resistance resulting from the use of antimicrobial veterinary medicinal products
carcinogenicity testing pre-authorisation studies to assess the potential for resistance resulting from the use of antimicrobial veterinary medicinal products

die bei diesen tests genutzten verfahren sollten der oecd-leitlinie 452 (chronic toxicity studies) oder 453 (combined chronic toxicity/carcinogenicity studies) entsprechen.
protocols should be in line with oecd guideline 452 (chronic toxicity study) or 453 (combined chronic toxicity/carcinogenicity study).